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Persistent inequalities in unplanned hospitalisation among
colon cancer patients across critical phases of their care
pathway, England, 2011–13
Camille Maringe1, Bernard Rachet1, Georgios Lyratzopoulos2 and Francisco Javier Rubio1
BACKGROUND: Reducing hospital emergency admissions is a key target for all modern health systems.
METHODS: We analysed colon cancer patients diagnosed in 2011–13 in England. We screened their individual Hospital Episode
Statistics records in the 90 days pre-diagnosis, the 90 days post-diagnosis, and the 90 days pre-death (in the year following
diagnosis), for the occurrence of hospital emergency admissions (HEAs).
RESULTS: Between a quarter and two thirds of patients experience HEA in the three 90-day periods examined: pre-diagnosis, post-
diagnosis and before death. Patients with tumour stage I-III from more deprived backgrounds had higher proportions of HEAs than
less deprived patients during all studied periods. This remains even after adjusting for differing distributions of risk factors such as
age, sex, comorbidity and stage at diagnosis.
CONCLUSIONS: Although in some cases HEAs might be unavoidable or even appropriate, the proportion of HEAs varies by
socioeconomic status, even after controlling for the usual patient factors, suggestive of remediable causes of excess emergency
healthcare utilisation in patients belonging to higher deprivation groups. Future inquiries should address the potential role of
clinical complications, sub-optimal healthcare administration, premature discharge or a lack of social support as potential
explanations for these patterns of inequality.
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INTRODUCTION
Hospital Emergency Admissions (or readmissions, HEAs) are
generally defined as unplanned admissions to hospital. In the
USA, rates of hospital emergency readmissions within 30 days are
used as indicators of quality of care, and hospitals can be
penalised if they present high rates of hospital readmissions.1 In
England, the National Health Service monitors 90-days unplanned
readmissions as an indicator of quality of care.2 HEAs have
financial implications, as unplanned hospital admissions are
more expensive than planned ones,3 and they utilise resources
from the already pressured Accident and Emergency (A&E)
department.4
In the context of cancer epidemiology in England, the literature
has mainly focused on understanding the causes for HEAs within
90 days following colorectal cancer resection,2 describing the
impact of deprivation on HEAs post-diagnosis in the Thames
region,5 or analysing differential access to hospital care.6,7
Recently, great attention has also been paid to the analysis and
impact of emergency presentations of cancer.8,9 However, there is
insufficient evidence concerning the joint analysis of hospital
admissions (HAs), elective or unplanned, of cancer patients in
England for different periods in their trajectories. Despite wide-
ranging causes for HEAs in different periods around the cancer
diagnosis, examining different aspects of the cancer pathway
jointly can reveal consistent patterns of variation for different
patient groups. Large variations in cancer outcomes by depriva-
tion remain unexplained by differential distribution of stage at
diagnosis and access to treatment.6,7,10 Deprivation-related
disparities in outcomes may be attributed to more complex
variations in management and care, difficult to measure at
population level. HEAs may be related to premature hospital
discharge, overlooking the severity of certain symptoms, a lack of
follow-up after the diagnosis and social support, or a delay in
elective admission.
We present the analysis of HEAs in three key periods: 90 days
pre-diagnosis, 90 days post-diagnosis and 90 days pre-death
(Fig. 1). Depending on tumour factors, such as stage at
diagnosis, these periods may be signs of (1) poor recognition
of signs and symptoms by both patients and doctors; (2) poor
quality discharge planning, poor social support, or a rapid
evolution of the disease; and (3) the quality of life of terminal
patients.
We report national proportions of HEAs for colon cancer
patients in England. We also study the variation of HEAs by
deprivation level. For both aims, we focus on the time period
between three months before and a year after the date
of diagnosis. To our knowledge, this is the first time the
topic of emergency admission in colon cancer patients by
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deprivation is studied nation-wide and along the cancer care
pathway.
METHODS
We analyse 65,020 records for patients diagnosed between 2011
and 2013 in England with a colon carcinoma (ICD-10 C18). These
were linked to the Hospital Episode Statistics (HES) in-patients and
A&E datasets that contain records of all hospital attendances
between 2003 and 2014.
Information on patients’ age, deprivation, comorbidity and
stage at diagnosis was available or derived11,12 from the cancer
registrations linked to the National Bowel Cancer Audit Data
(NBOCAT) and HES. Deprivation is measured at the Lower Super
Output Area (LSOA) level (mean population 1500), using the Index
for Multiple Deprivation (IMD) income domain.13 The IMD scores
are ranked and split according to quintiles of their national
distribution, thereby dividing the LSOAs in five groups of
increasing deprivation. Patients are allocated to a deprivation
group given their LSOA of residence at the time of diagnosis.
Stage at diagnosis was classified using the Tumour, Node and
Metastasis (TNM) staging system.14 Comorbidity information was
derived from the HES data:11 A binary variable identifies comorbid
patients. We checked the HES records in the 8 years preceding the
colon cancer diagnosis for the occurrence of any of the 17
comorbidities that forms part of the Charlson score,15 or morbid
obesity, given evidence that it may moderate decisions about
surgical management and prognosis. For each patient, a
diagnostic route, representing different types of care pathways
to a diagnosis of cancer, was assigned by Public Health England
using an algorithm based on linked data from cancer registration,
Hospital Episodes Statistics, National Cancer Waiting Times and
National Bowel Cancer Screening Programme.16
From the HES dataset, we defined unplanned admissions as: (i)
any A&E admissions, and (ii) in-patient admissions where the
method of admission (admimeth variable) was coded as “Emer-
gency Admission, when admission is unpredictable and at short
notice because of clinical need”.17 We looked at the admission
status of the first or unique episode of a spell.18
We presented the analysis of HEAs in three key periods along
the course of the disease: (1) 90 days pre-diagnosis, (2) 90 days
post-diagnosis; and (3) 90 days pre-death (Fig. 1). Thus, the date of
diagnosis as defined by the United Kingdom and Ireland
Association of Cancer Registries (UKIACR) represents the reference
point, around which we define pre- and post-diagnosis periods. In
the 90 days pre-diagnosis, the 65,020 colon cancer patients could
experience two possible outcomes: those diagnosed with cancer
after one or more HEAs, and those diagnosed with cancer without
any HEAs. In the 90 days post-diagnosis, these patients could be in
one of four possible outcomes defined by the combination of their
emergency admission status and vital status at 90 days. Analysing
separately the patients who die before the end of the observation
period is essential to avoid the phenomenon of “immortal bias”.19
We then selected patients who died between the 90th day and
12th month after diagnosis (n= 8681), and examined whether
they had records of HEAs in the 90 days preceding death.
Therefore, patients who had died within the first three months of
diagnosis, or patients who were alive after a year did not form part
of this sub-analysis.
Because of our prior interest in deprivation-related inequalities
in HEAs, we presented proportions of HEAs by deprivation
quintile. Since stage distribution varies by deprivation, and both
stage and deprivation are associated with the occurrence of HEAs,
we presented stratified analyses of HEAs by deprivation and stage
at diagnosis (and route to diagnosis). The text often highlights
differences between the two extreme deprivation groups (i.e.
deprivation 1 and 5). The gradients, for the outcomes of interest,
between all deprivation groups are given in tables and graphs.
In order to account further for differential distributions of risk
factors between deprivation groups, we calculated indirectly
standardised rates of emergency admissions for the most
deprived patients in the 90 days following their colon cancer
diagnosis. We applied the sex, age and comorbidity distribution of
patients in the least deprived group, stratified by stage at
diagnosis, to patients of the most deprived group. We can
interpret the values as hypothetical proportions of HEA that would
be observed in the most deprived category, had patients been
subjected to the sex, age, and comorbidity allocation of least
deprived patients. Given sex and age vary little by deprivation
generally, it is a crude estimation of the role of comorbidity in the
differential proportions of HEA between deprivation levels. We
similarly calculated sex, age, comorbidity and stage-standardised
rates restricted to patients with complete information on their
stage at diagnosis.
RESULTS
Inequalities in HEA by patient factors
Pre-diagnosis. In the 90 days preceding their colon cancer
diagnosis, over a third (38%) of patients experienced at least
one HEA (Table 1). Over half of the first of these pre-diagnosis
HEAs occurred in the 30 days prior to diagnosis (Fig. 2a).
These HEA events were somewhat more frequent among
women (40% vs 36% in men, p < 0.001), and substantially more
frequent among patients subsequently diagnosed at more
advanced stage (47% vs 18% for patients diagnosed at stages IV
and I, respectively, p= 0.023), those with increasing deprivation
(46% vs 33% in least and most deprived patients, respectively, p=
0.001) and those with at least one comorbidity (48% vs 31%
among those without, p < 0.001, Table 1).
Post-diagnosis. Up to 15% of patients died in the 90 days
following their colon cancer diagnosis, including 5% after at least
one HEA. There are marked differences by stage at diagnosis, with
increasing proportions of patients who died with or without HEA
with increasing stage (Table 1). Patients who died within the first
90 days after their diagnosis were 78.6 years compared to 71 years
for those who survived that period. There is some variation in the
proportions of patients dying, with (p= 0.001) or without (p <
0.001) HEA, by deprivation.
Among the majority of patients who survived to 3 months, HEAs
were observed in 22%. This proportion varied little by sex, and
comorbidity, but was substantially greater in more deprived
patients (p= 0.018) and those diagnosed in advanced stage
Note: the cancer diagnosis may be part of a spell, elective or emergency
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Fig. 1 Diagram showing the different analysis periods. a 90 days pre-diagnosis, b 90 days post-diagnosis, and c 90 days pre-death (when
death occurred in the 90 days to 1 year following diagnosis)
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(p= 0.027, Table 1). Overall, there were higher proportions of
patients without comorbidities (67%), stage I disease (81%), and
least deprived (66%) who did not experience any HEA during the
3 months post-diagnosis than those patients with comorbidities
(56%), stage IV disease (44%) or most deprived (57%) (Table 1).
There was a sharp increase in proportions of patients dying
(with or without HEA) in the first days after diagnosis, and that
increase flattened out after 20–30 days after diagnosis. On the
contrary, the proportions of HEAs kept increasing through to
90 days after diagnosis (Fig. 2b).
Pre-death. Among the 8,681 patients who died between 90 days
and a year of their colon cancer diagnosis, on average 67%
experienced at least one HEA in the 90 days prior to their death
(Table 1 and Fig. 2c). Such HEA events were more common among
male (69% vs 65% in female, p < 0.001) and more deprived (72%
to 65% from most to least deprived, p= 0.008) fatal cases. There
was a constant increase in the proportion of patients with HEA
with increasing time to death (Fig. 2c).
Missing information on stage was affecting between 20% (alive
patients with a HEA after diagnosis) and 39% (patients who died
without HEA in the 90 days after diagnosis) of patients.
Diagnostic route
Diagnostic route was linked to patterns of HEAs pre-diagnosis and
the proportions of HEAs post-diagnosis and pre-death, when
death happened in the 90 days to first year after the diagnosis
(Annex 1). Patients diagnosed through screening had lowest
proportions of HEAs at all times (<5%), in contrast to patients
diagnosed via Emergency, which showed higher proportions of
HEAs or death. In the 90 days pre-diagnosis, patients diagnosed
through the two-week-wait had low proportions of HEAs (5–10%).
In the 90 days post diagnosis, patients diagnosed following GP
referral, in-patient elective, other outpatient and two-week-wait
had lower proportions of death (with or without HEAs, 10% or
less), but similar proportions of patients with one or more HEAs to
patients diagnosed through emergency or unknown routes
(~20%), see Annex 1.
Stage-specific deprivation-related inequalities in HEA
Around the time of diagnosis, there were linearly increasing
proportions of patients with adverse outcomes (HEAs pre- and
post-diagnosis and death within 90 days of diagnosis, Annex 2A&B)
with increasing deprivation (Fig. 3a, b), at all stages at diagnosis.
The discrepancy in adverse outcomes between deprivation groups
Table 1. Distribution of the outcomes by patient characteristics, within each period, of the 65,020 patients diagnosed with colon cancer in England
in 2011–13
90-day pre-diagnosis 90-day post-diagnosis 90-day pre-death
(N = 8681)
Alive Alive after HEA Alive Alive after
HEA
Death Death after
HEA
Death Death after
HEA
N % N % N % N % N % N % N % N %
Total 40,498 62.3 24,522 37.7 40,688 62.6 14,441 22.2 6689 10.3 3202 4.9 2872 33.1 5809 66.9
Age at diagnosis
(mean age)
71.7 72.7 71.2 70.1 80.0 75.5 78.6 74.5
Sex
F 18,598 60.2 12,301 39.8 19,078 61.7 6803 22.0 3526 11.4 1492 4.8 1522 35.5 2768 64.5
M 21,900 64.2 12,221 35.8 21,610 63.3 7638 22.4 3163 9.3 1710 5.0 1350 30.7 3041 69.3
p-value <0.001a <0.001b < 0.001a
Deprivation
1 9602 67.3 4670 32.7 9412 65.9 3018 21.1 1222 8.6 620 4.3 635 35.5 1153 64.5
2 9342 65.0 5039 35.0 9282 64.5 3065 21.3 1360 9.5 674 4.7 649 34.7 1223 65.3
3 8604 62.8 5087 37.2 8669 63.3 2923 21.3 1439 10.5 660 4.8 605 33.3 1214 66.7
4 7553 59.2 5209 40.8 7661 60.0 2955 23.2 1457 11.4 689 5.4 581 32.4 1210 67.6
5 5397 54.4 4517 45.6 5664 57.1 2480 25.0 1211 12.2 559 5.6 402 28.5 1009 71.5
p-value 0.001c 0.001c 0.002c 0.018c <0.001c 0.001c 0.008c 0.008c
Stage at diagnosis
1 5550 81.9 1230 18.1 5467 80.6 1176 17.3 88 1.3 49 0.7 76 37.3 128 62.7
2 9708 65.3 5160 34.7 10,846 72.9 3257 21.9 578 3.9 187 1.3 222 30.8 499 69.2
3 8479 63.8 4808 36.2 9176 69.1 3301 24.8 557 4.2 253 1.9 364 28.2 927 71.8
4 8111 52.8 7247 47.2 6681 43.5 3885 25.3 2876 18.7 1916 12.5 1407 32.5 2925 67.5
p-value 0.023c 0.023c 0.038c 0.027c 0.071c 0.087c 0.214c 0.214c
Missing stage 8650 58.7 6077 41.3 8518 57.8 2822 19.2 2590 17.6 797 5.4 803 37.6 1330 62.4
Comorbidity
0 26,474 69.3 11,752 30.7 25,587 66.9 8362 21.9 2666 7.0 1611 4.2 1443 32.8 2960 67.2
1 14,024 52.3 12,770 47.7 15,101 56.4 6079 22.7 4023 15.0 1591 5.9 1429 33.4 2849 66.6
p-value <0.001a <0.001b 0.538a
aFisher’s test for count data. Tests for the equality of two binomial populations. The test was performed with the R command fisher.test() bChi-square test. Tests
for the equality of two multinomial populations. The test was performed with the R command chisq.test() cCorrelation test for trend: Test for a positive or
negative correlation of the means. The p-values correspond to one-sided tests. The p-value is obtained with the R command cor.test()
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for patients dying in their first year was less striking at stages I–III,
but still evident for patients diagnosed at stage IV or missing stage
(Fig. 3c).
Before the diagnosis, the proportions of patients with at least
one HEA differed between least and most deprived (Table 2):
respectively 28% and 40% of stage I–III patients, 42% and 55% of
stage IV patients, and 36% and 50% of missing stage patients had
HEAs before their cancer diagnosis. Those differences by depriva-
tion remained in the 90 days after diagnosis for patients diagnosed
at stages I–III or with no valid stage recorded. Patients diagnosed
at stage IV did not show striking variations by deprivation in
the proportions of each of the four outcomes in the 90 days
following diagnosis and patterns through time were similar
across deprivation groups. In the 90 days pre-death, most deprived
patients had between 5% and 7% higher proportions of
death within 90 days of one or more HEAs than least deprived
patients.
Considering observed non-standardised proportions, it is
apparent that overall most deprived patients had higher propor-
tions of all types of HEA’s events studied (across all three 90-day
periods of interest), particularly for patients in stages I–III (Table 2).
In these groups, proportions of adverse outcomes remained
higher in most deprived compared to least deprived patients,
even after removing the impact that differential distributions of
sex, age, and comorbidity (and stage) might have on those
proportions.
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Table 2. Proportions of each outcome (with 95% CI), 90 days after diagnosis, for least and most deprived patients. Indirectly standardised
proportionsa for most deprived patients
Deprivation Standardised proportions (most deprived)
Outcome Stage Least Most Age, sex Age, sex, comorbidity Age, sex, comorb., stage (Complete case)b
a. 90 days pre diagnosis
Proportion with HEA
I–III 27.7% 39.7% 39.2% 37.0%
95% CI 26.7%;28.7% 38.3%;41.0% 37.9%;40.5% 35.7%;38.3%
IV 41.8% 54.5% 54.2% 51.7%
95% CI 40.1%;43.5% 52.5%;56.5% 52.2%;56.2% 49.7%;53.7%
Missing 35.6% 49.9% 48.7% 46.4%
95% CI 34.0%;37.3% 47.8%;51.9% 46.6%;50.7% 44.4%;48.5%
All (complete case)b 31.9% 44.3% 41.3%
95% CI 31.0%;32.8% 43.2%;45.4% 40.2%;42.4%
b. 90 days post diagnosis
Dead
I–III 2.7% 4.7% 5.0% 4.4%
95% CI 2.4%;3.1% 4.1%;5.3% 4.4%;5.6% 3.9%;5.0%
IV 16.7% 19.0% 20.0% 19.4%
95% CI 15.4%;18.0% 17.4%;20.6% 18.3%;21.6% 17.8%;21.0%
Missing 14.5% 22.4% 22.1% 21.5%
95% CI 13.2%;15.7% 20.7%;24.1% 20.4%;23.8% 19.8%;23.2%
All (complete case)b 6.9% 9.2% 8.9%
95% CI 6.4%;7.4% 8.5%;9.8% 8.2%;0.0%
Proportion with HEA
Dead
I–III 1.1% 1.8% 1.9% 1.8%
95% CI 0.9%;1.3% 1.4%;2.1% 1.5%;2.2% 1.4%;2.1%
IV 11.9% 13.9% 14.1% 13.8%
95% CI 10.8%;13.0% 12.5%;15.2% 12.7%;15.6% 12.4%;15.2%
Missing 4.5% 6.0% 6.0% 5.8%
95% CI 3.7%;5.2% 5.0%;7.0% 5.0%;6.9% 4.8%;6.7%
All (complete case)b 4.3% 5.5% 5.3%
95% CI 3.9%;4.7% 5.0%;6.0% 4.8%;5.8%
Alive
I–III 20.7% 26.0% 25.6% 24.9%
95% CI 19.8%;21.6% 24.8%;27.2% 24.4%;26.8% 23.7%;26.1%
IV 25.7% 26.5% 25.4% 25.4%
95% CI 24.2%;27.2% 24.8%;28.3% 23.6%;27.1% 23.6%;27.1%
Missing 17.6% 21.1% 21.3% 20.8%
95% CI 16.3%;18.9% 19.4%;22.8% 19.6%;22.9% 19.1%;22.5%
All (complete case)b 22.1% 26.2% 25.1%
95% CI 21.4%;22.9% 25.2%;27.2% 24.1%;26.0%
c. 90 days pre death
Proportion with HEA
I–III 68.2% 73.1% 72.3% 71.5%
95% CI 63.8%;72.6% 68.8%;77.4% 67.9%;76.6% 67.1%;75.9%
IV 65.1% 73.0% 71.4% 70.7%
95% CI 62.0%;68.2% 69.6%;76.3% 67.9%;74.8% 67.2%;74.1%
Missing 59.0% 66.9% 66.9% 65.0%
95% CI 54.3%;63.6% 61.9%;71.8% 61.9%;71.8% 59.9%;70.0%
All (complete case)b 66.1% 73.0% 70.9%
95% CI 63.6%;68.6% 70.3%;75.7% 68.2%;73.7%
aIndirect standardisation of proportions for most deprived patients use the age and sex, age, sex and comorbidity by stage, and age, sex, comorbidity and
stage distributions observed in least deprived patients. bComplete cases are patients with a valid record of stage
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Patients diagnosed at stage IV had slightly overlapping 95%
confidence intervals around their proportions of outcomes in the
90 days following diagnosis, suggesting a milder deprivation gap
in this sub-group.
Indirect standardisation, i.e. applying the distributions of age,
sex, comorbidity and stage observed in the least deprived patients
to the most deprived patients, hardly changed the proportions of
any of the outcomes studied in all three time-periods among the
most deprived patients. That is, the most deprived group of
patients experience higher proportions of emergency healthcare
than the least deprived group.
In all three phases of the care pathway studied, both the least
and the most deprived groups showed similar increasing trends
with time in their proportions of each outcome (Annex 2). Trends
in elective admissions were identical in least and most deprived
patients (Annex 3).
DISCUSSION
In the 90 days before the diagnosis, over a third of patients
experience at least one HEA, in line with the reported proportions
of patients diagnosed via emergency presentation within 28 days
of diagnosis.16 In total 85% of the patients survived the 90 days
post-diagnosis and a quarter of them experienced at least one
HEA in this period. By contrast, among the remaining 15% who
died, a third (i.e. 5% of all patients) experienced at least one HEA in
this post-diagnosis period. The proportion of patients who
experienced at least one HEA rose to two thirds in the 90 days
pre-death, among those who died in the first year after diagnosis.
Our study highlights a clear deprivation-related variability for
patients diagnosed at stages I–III: patients from more deprived
background exhibit higher rates of HEAs than least deprived
patients (with a decreasing gradient for intermediate deprivation
levels) pre- and post-diagnosis. This phenomenon is not explained
by differences in the distribution of age, sex, presence of
comorbidity, and stage of disease. This is in line with the results
found in the US20 and in the England Thames region.5 In contrast,
we did not find large differences in the proportions of elective
admissions across deprivation groups in the 90 days following
diagnosis. Stage IV patients exhibit less marked deprivation-
related variability in terms of HEAs, which may be related to the
terminal status of those patients.
These analyses are based on all colon cancer patients
diagnosed in England in the years 2011–13. The patients’ records
were linked to the A&E and in-patient hospital data. Any
differences between groups of patients highlighted here are not
likely due to chance given the population-based nature of the
data. We defined the emergency status of a spell in HES18 based
on the first or unique HES episode of that spell, i.e. the emergency
status of further episodes of a spell are not considered.
Another contribution of this work is that it provides appropriate
descriptive tools for HEA data. More specifically, given that in the
90 days after the diagnosis some patients die, it implies that, for
those patients, the events of interest (HEAs) cannot occur in a
certain period during the follow-up time, i.e. in the time following
death. This phenomenon is known as immortal bias19 and needs
to be taken into account in order to avoid drawing biased
conclusions.
A limitation of our analysis is that it excludes elective and
emergency admissions to private hospitals. This may induce a
slight under estimation of the number of admissions in the least
deprived group, which is the most likely group to attend private
hospitals. Nevertheless, we do not expect the inclusion of such
admissions to private hospitals to affect the conclusions presented
in this paper.21
This study highlights consistent patterns of increased proportions
of HEA with increasing deprivation among the colon cancer patients
at stages I–III. Similar patterns have been reported in the general
population.22 These are stable throughout the diagnosis and
treatment pathways. Furthermore, we emphasise that there are
differences between deprivation groups before the diagnosis, i.e.
when patients are still considered part of the general population.
Interestingly, once patients are diagnosed, and should therefore
undertake the same scrutinised treatment and follow-up for their
disease, the difference between deprivation groups remains, even
after the influence of case-mix factors is taken into account. This is
suggestive of differential management as well as the potential
contribution of different socio-cultural factors including use of
hospital and palliative care, family and social support, and hospital
as a place of death. Evidence of this may be found in late-stage
patients dying in the year following their colon cancer diagnosis,
whereby most healthcare need can be assumed to relate to
palliative care and support. Least deprived patients show, perhaps
unavoidable, high proportions of HEAs in the 90 days pre-death
(65%), but up to 72% of most deprived patients visit A&E prior to
death—the difference in these percentages can provide a
measure of potentially avoidable HEAs in the most deprived
group.
Comorbidity information was captured from linkage of the HES
records to the cancer registration dataset for the years preceding
diagnosis.11 Comorbidities derived using HES diagnostic codes
provide a valid assessment of the health status of patients.23,24 An
8-year period before the colon cancer diagnosis was used to
classify comorbid patients. This represents the largest assessment
period available for patients diagnosed in 2011, and therefore
minimises misclassification of patients into the “not-comorbid”
category when in fact they are comorbid.
These results point out that there is an excess of potentially
avoidable HEAs in the more deprived groups compared to the
least deprived group. In order to reduce HEAs, interventions
should focus on deprived groups and aim at integrating social and
health care. For instance, patients that exhibit recurrent HEAs in a
short period of time reflect either clinical complications, sub-
optimal healthcare administration, premature discharge or a lack
of social support. Disentangling the causes for recurrent HEAs
requires a case by case analysis, and an efficient communication
with the health professionals.
The aim of these analyses is to be paving the way for a more
systematic study of hospital emergency admissions for cancer
patients in different periods along their diagnosis pathways.
Although we chiefly focus on deprivation-related inequalities in
hospital admissions, studying other types of inequalities is also
relevant. For instance, the factors (clinical or managerial) behind
the observed differences in HEAs between male and female
patients in the pre-diagnosis period deserve further investiga-
tion.25 Nonetheless, a lot of information is available in the hospital
data, such as admission codes, length of stay, details of the
consultant caring for the patients, and cost of the hospital
admissions. Identifying, extracting and synthesising further data
items is key to understand better the differences in emergency
access to healthcare around a colon cancer diagnosis, identify and
characterise sub-optimal pathways.
In the different periods, the trajectories of cancer patients can
be of very different nature due to wide-ranging causes. A lack of
cancer symptoms awareness (patient-level) and sub-optimal
management, including delay in the medical attention or
premature discharge (system-level) can affect the occurrence
and recurrence of HEAs.
In the 90 days before the diagnosis, there are opportunities for a
timely diagnosis and earlier detection of people with signs and
symptoms suggestive of cancer.26 In the 90 days after the
diagnosis, reducing HEAs may help provide optimal healthcare
and treatment assignment. Receiving healthcare attention in HEAs
is far from being the optimal healthcare pathway. Looking at
patients who die within a year, 80% of them had an elective
admission within 90 days of their death, happening, on average,
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around two months before death. However, roughly twice the
proportion of most deprived patients die after a HEA, with no
elective admissions, compared to the least deprived group.
Initiatives to allow patients to decide where to be cared for and
where to die are already in place (e.g. The Marie Curie Cancer Care
Delivering Choice Programme).27 However, given the differences
in HEAs by deprivation that we emphasise, it is important to make
sure that these initiatives are being made available equally to all
patients, regardless of their socioeconomic background, and that
the patients’ choice is well informed.
Given the financial and prognostic implications of HEAs, it is
important to understand the patterns of hospital admissions of
cancer patients. Identifying the characteristics of patients asso-
ciated with higher proportions of HEAs helps targeting campaigns
and policies on vulnerable sectors. Our study identifies cancer
patient groups at higher risk of emergency admissions, which can
be considered by UK healthcare providers to plan consultation
rates, follow-up strategies, comorbidity management, and social
support to help reduce the rate of HEAs.
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